1-171278765-G-A
Variant summary
Our verdict is Uncertain significance. Variant got 1 ACMG points: 2P and 1B. PM2BP4
The NM_001282693.2(FMO1):c.521G>A(p.Arg174Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000168 in 1,609,334 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R174W) has been classified as Uncertain significance.
Frequency
Consequence
NM_001282693.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 1 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FMO1 | NM_001282693.2 | c.521G>A | p.Arg174Gln | missense_variant | 5/9 | ENST00000617670.6 | NP_001269622.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FMO1 | ENST00000617670.6 | c.521G>A | p.Arg174Gln | missense_variant | 5/9 | 1 | NM_001282693.2 | ENSP00000481732.1 |
Frequencies
GnomAD3 genomes AF: 0.0000460 AC: 7AN: 152014Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000240 AC: 6AN: 250302Hom.: 0 AF XY: 0.00000739 AC XY: 1AN XY: 135280
GnomAD4 exome AF: 0.0000137 AC: 20AN: 1457320Hom.: 0 Cov.: 29 AF XY: 0.00000965 AC XY: 7AN XY: 725164
GnomAD4 genome AF: 0.0000460 AC: 7AN: 152014Hom.: 0 Cov.: 32 AF XY: 0.0000539 AC XY: 4AN XY: 74238
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 23, 2024 | The c.521G>A (p.R174Q) alteration is located in exon 5 (coding exon 4) of the FMO1 gene. This alteration results from a G to A substitution at nucleotide position 521, causing the arginine (R) at amino acid position 174 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at